Download PDF
Planta Med 2016; 82(11/12): 1000-1008
DOI: 10.1055/s-0042-105158
Biological and Pharmacological Activity
Original Papers
Georg Thieme Verlag KG Stuttgart · New York

A Polyphenol-Enriched Fraction of Rose Oil Distillation Wastewater Inhibits Cell Proliferation, Migration and TNF-α-Induced VEGF Secretion in Human Immortalized Keratinocytes[*]

Jonas Wedler
1   Institute for Pharma Technology, School of Life Sciences, University of Applied Sciences Northwestern Switzerland, Muttenz, Switzerland
,
Krasimir Rusanov
2   AgroBioInstitute, Sofia, Bulgaria
,
Ivan Atanassov
2   AgroBioInstitute, Sofia, Bulgaria
,
Veronika Butterweck
1   Institute for Pharma Technology, School of Life Sciences, University of Applied Sciences Northwestern Switzerland, Muttenz, Switzerland
› Author Affiliations
Further Information

Publication History

received 04 February 2016
revised 06 March 2016

accepted 10 March 2016

Publication Date:
19 April 2016 (online)

    Permissions and Reprints

Abstract

Water steam distillation of rose flowers separates the essential oil from the polyphenol-containing rose oil distillation wastewater. Recently, a strategy was developed to separate rose oil distillation wastewater into a polyphenol depleted water fraction and a polyphenol-enriched fraction [RF20-(SP-207)]. The objective of the present study was to investigate RF20-(SP-207) and fraction F(IV), augmented in quercetin and ellagic acid, for possible antiproliferative effects in immortalized human keratinocytes (HaCaT) since rose petals are known to contain compounds with potential antiproliferative activity.

RF20-(SP-207) revealed dose-dependent antiproliferative activity (IC50 of 9.78 µg/mL). In a nontoxic concentration of 10 µg/mL, this effect was stronger than that of the two positive controls LY294002 (10 µM, PI3 K-inhibitor, 30 % inhibition) and NVP-BEZ235 (100 nM, dual PI3 K/mTOR inhibitor, 30 % inhibition) and clearly exceeded the antiproliferative action of quercetin (50 µM, 25 % inhibition) and ellagic acid (1 µM, 15 % inhibition). Time-lapse microscopy detected a significant impairment of cell migration of RF20-(SP-207) and F(IV). At concentrations of 10 µg/mL of both, extract and fraction, cell migration was strongly suppressed (51 % and 28 % gap closure, respectively, compared to 95 % gap closure 24 hours after control treatment). The suppression of cell migration was comparable to the positive controls LY294002, NVP-BEZ235, and quercetin. Furthermore, basal and TNF-α-stimulated VEGF-secretion was significantly reduced by RF20-(SP-207) and F(IV) at 10 µg/mL (44 % vs. untreated control).

In conclusion, RF20-(SP-207) showed promising antiproliferative and antimigratory effects and could be developed as a supportive, therapy against hyperproliferation-involved skin diseases.

Key words

Rosa damascene - Rosaceae - wastewater - quercetin - ellagic acid - cell proliferation - cell migration - VEGF

* Dedicated to Prof. Dr. Dr. h. c. mult. Kurt Hostettmann in recognition of his outstanding contribution to natural product research.


 

  • References

  • 1 Boskabady MH, Shafei MN, Saberi Z, Amini S. Pharmacological effects of Rosa damascena . Iran J Basic Med Sci 2011; 4: 295-307
    PubMedGoogle Scholar
  • 2 Rusanov K, Kovacheva N, Atanassov A, Atanassov I. Rosa damascena mill., the oil-bearing damask rose: genetic resources, diversity and perspectives for molecular breeding. Floriculture Ornamental Biotech 2009; 3: 14-20
    PubMedGoogle Scholar
  • 3 Rusanov K, Garo E, Rusanova M, Fertig O, Hamburger M, Atanassov I, Butterweck V. Recovery of polyphenols from rose oil distillation wastewater using adsorption resins – a pilot study. Planta Med 2014; 80: 1657-1664
    Article in Thieme ConnectPubMedGoogle Scholar
  • 4 Fresco P, Borges F, Marques MP, Diniz C. The anticancer properties of dietary polyphenols and its relation with apoptosis. Curr Pharm Des 2010; 16: 114-134
    CrossrefPubMedGoogle Scholar
  • 5 Tomas-Barberan FA, Garcia-Villalba R, Gonzalez-Sarrias A, Selma MV, Espin JC. Ellagic acid metabolism by human gut microbiota: consistent observation of three urolithin phenotypes in intervention trials, independent of food source, age, and health status. J Agric Food Chem 2014; 62: 6535-6538
    CrossrefPubMedGoogle Scholar
  • 6 DallʼAsta M, Calani L, Tedeschi M, Jechiu L, Brighenti F, Del Rio D. Identification of microbial metabolites derived from in vitro fecal fermentation of different polyphenolic food sources. Nutrition 2012; 28: 197-203
    CrossrefPubMedGoogle Scholar
  • 7 Gerhauser C. Cancer chemopreventive potential of apples, apple juice, and apple components. Planta Med 2008; 74: 1608-1624
    Article in Thieme ConnectPubMedGoogle Scholar
  • 8 Solimine J, Garo E, Wedler J, Rusanov K, Fertig O, Hamburger M, Atanassov I, Butterweck V. Tyrosinase inhibitory constituents from a polyphenol enriched fraction of rose oil distillation wastewater. Fitoterapia 2016; 108: 13-19
    CrossrefPubMedGoogle Scholar
  • 9 Bruggisser R, von Daeniken K, Jundt G, Schaffner W, Tullberg-Reinert H. Interference of plant extracts, phytoestrogens and antioxidants with the MTT tetrazolium assay. Planta Med 2002; 68: 445-448
    Article in Thieme ConnectPubMedGoogle Scholar
  • 10 Wang P, Henning SM, Heber D. Limitations of MTT and MTS-based assays for measurement of antiproliferative activity of green tea polyphenols. PLoS One 2010; 5: e10202
    CrossrefPubMedGoogle Scholar
  • 11 Wisman KN, Perkins AA, Jeffers MD, Hagerman AE. Accurate assessment of the bioactivities of redox-active polyphenolics in cell culture. J Agric Food Chem 2008; 56: 7831-7837
    CrossrefPubMedGoogle Scholar
  • 12 Verjee S, Brügger D, Abdel-Aziz H, Butterweck V. Permeation characteristics of hypericin across Caco-2 monolayers in the absence or presence of quercitrin – a mass balance study. Planta Med 2015; 81: 1111-1120
    Article in Thieme ConnectPubMedGoogle Scholar
  • 13 Jiang H, Fan D, Zhou G, Li X, Deng H. Phosphatidylinositol 3-kinase inhibitor(LY294002) induces apoptosis of human nasopharyngeal carcinoma in vitro and in vivo . J Exp Clin Cancer Res 2010; 29: 34
    CrossrefPubMedGoogle Scholar
  • 14 Lasithiotakis KG, Sinnberg TW, Schittek B, Flaherty KT, Kulms D, Maczey E, Garbe C, Meier FE. Combined inhibition of MAPK and mTOR signaling inhibits growth, induces cell death, and abrogates invasive growth of melanoma cells. J Invest Dermatol 2008; 128: 2013-2023
    CrossrefPubMedGoogle Scholar
  • 15 Slominski AT, Zmijewski MA, Zbytek B, Tobin DJ, Theoharides TC, Rivier J. Key role of CRF in the skin stress response system. Endocr Rev 2013; 34: 827-884
    CrossrefPubMedGoogle Scholar
  • 16 Sabat R, Philipp S, Höflich C, Kreutzer S, Wallace E, Asadullah K, Volk HD, Sterry W, Wolk K. Immunopathogenesis of psoriasis. Exp Dermatol 2007; 16: 779-798
    CrossrefPubMedGoogle Scholar
  • 17 Keystone EC. Does anti-tumor necrosis factor-alpha therrapy affect risk of serious infection and cancer in patients with rheumatoid arthritis?: a review of longterm data. J Rheumatol 2011; 38: 1552-1562
    CrossrefPubMedGoogle Scholar
  • 18 Olivieri I, DʼAngelo S, Palazzi C, Padula A. Treatment strategies for early psoriatic arthritis. Expert Opin Pharmacother 2009; 10: 271-282
    CrossrefPubMedGoogle Scholar
  • 19 Brotas AM, Cunha JMT, Lago EHJ, Machado CCN, Carneiro SCD. Tumor necrosis factor-alpha and the cytokine network in psoriasis. An Bras Dermatol 2012; 87: 673-683
    CrossrefPubMedGoogle Scholar
  • 20 Wilgus TA, Matthies AM, Radek KA, Dovi JV, Burns AL, Shankar R, DiPietro LA. Novel function for vascular endothelial growth factor receptor-1 on epidermal keratinocytes. Am J Pathol 2005; 167: 1257-1266
    CrossrefPubMedGoogle Scholar
  • 21 Ferrara N. Vascular endothelial growth factor: basic science and clinical progress. Endocr Rev 2004; 25: 581-611
    CrossrefPubMedGoogle Scholar
  • 22 Li W, Man XY, Chen JQ, Zhou J, Cai SQ, Zheng M. Targeting VEGF/VEGFR in the treatment of psoriasis. Discov Med 2014; 18: 97-104
    PubMedGoogle Scholar
  • 23 Weidemann AK, Crawshaw AA, Byrne E, Young HS. Vascular endothelial growth factor inhibitors: investigational therapies for the treatment of psoriasis. Clin Cosmet Investig Dermatol 2013; 6: 233-244
    PubMedGoogle Scholar
  • 24 Cao HH, Cheng CY, Su T, Fu XQ, Guo H, Li T, Tse AK, Kwan HY, Yu H, Yu ZL. Quercetin inhibits HGF/c-Met signaling and HGF-stimulated melanoma cell migration and invasion. Mol Cancer 2015; 14: 103
    CrossrefPubMedGoogle Scholar
  • 25 Labrecque L, Lamy S, Chapus A, Mihoubi S, Durocher Y, Cass B, Bojanowski MW, Gingras D, Beliveau R. Combined inhibition of PDGF and VEGF receptors by ellagic acid, a dietary-derived phenolic compound. Carcinogenesis 2005; 26: 821-826
    CrossrefPubMedGoogle Scholar
  • 26 Wang N, Wang ZY, Mo SL, Loo TY, Wang DM, Luo HB, Yang DP, Chen YL, Shen JG, Chen JP. Ellagic acid, a phenolic compound, exerts anti-angiogenesis effects via VEGFR-2 signaling pathway in breast cancer. Breast Cancer Res Treat 2012; 134: 943-955
    CrossrefPubMedGoogle Scholar
  • 27 Bae JY, Choi JS, Kang SW, Lee YJ, Park J, Kang YH. Dietary compound ellagic acid alleviates skin wrinkle and inflammation induced by UV-B irradiation. Exp Dermatol 2010; 19: e182-190
    CrossrefPubMedGoogle Scholar
  • 28 Lembo S, Balato A, Di Caprio R, Cirillo T, Giannini V, Gasparri F, Monfrecola G. The modulatory effect of ellagic acid and rosmarinic acid on ultraviolet-B-induced cytokine/chemokine gene expression in skin keratinocyte (HaCaT) cells. Biomed Res Int 2014; 2014: 346793
    PubMedGoogle Scholar
  • 29 Losso JN, Bansode RR, Trappey A, Bawadi HA, Truax R. In vitro anti-proliferative activities of ellagic acid. J Nutr Biochem 2004; 15: 672-678
    CrossrefPubMedGoogle Scholar
  • 30 Mertens-Talcott SU, Talcott ST, Percival SS. Low concentrations of quercetin and ellagic acid synergistically influence proliferation, cytotoxicity and apoptosis in MOLT-4 human leukemia cells. J Nutr 2003; 133: 2669-2674
    PubMedGoogle Scholar
  • 31 Cao HH, Tse AK, Kwan HY, Yu H, Cheng CY, Su T, Fong WF, Yu ZL. Quercetin exerts anti-melanoma activities and inhibits STAT3 signaling. Biochem Pharmacol 2014; 87: 424-434
    CrossrefPubMedGoogle Scholar
  • 32 Li F, Bai Y, Zhao M, Huang L, Li S, Li X, Chen Y. Quercetin inhibits vascular endothelial growth factor-induced choroidal and retinal angiogenesis in vitro . Ophthalmic Res 2015; 53: 109-116
    CrossrefPubMedGoogle Scholar
  • 33 Redondo P, Jimenez E, Perez A, Garcia-Foncillas J. N-acetylcysteine downregulates vascular endothelial growth factor production by human keratinocytes in vitro . Arch Dermatol Res 2000; 292: 621-628
    CrossrefPubMedGoogle Scholar
  • 34 Weng Z, Patel AB, Vasiadi M, Therianou A, Theoharides TC. Luteolin inhibits human keratinocyte activation and decreases NF-kappa B induction that is increased in psoriatic skin. PLoS One 2014; 9: e90739
    CrossrefPubMedGoogle Scholar
  • 35 Wedler J, Daubitz T, Schlotterbeck G, Butterweck V. In vitro anti-inflammatory and wound-healing potential of a Phyllostachys edulis leaf extract – identification of isoorientin as an active compound. Planta Med 2014; 80: 1678-1684
    Article in Thieme ConnectPubMedGoogle Scholar
  • 36 Lauffenburger DA, Horwitz AF. Cell migration: a physically integrated molecular process. Cell 1996; 84: 359-369
    CrossrefPubMedGoogle Scholar
  • 37 Pratheeshkumar P, Budhraja A, Son YO, Wang X, Zhang Z, Ding S, Wang L, Hitron A, Lee JC, Xu M, Chen G, Luo J, Shi X. Quercetin inhibits angiogenesis mediated human prostate tumor growth by targeting VEGFR- 2 regulated AKT/mTOR/P70S6 K signaling pathways. PLoS One 2012; 7: e47516
    CrossrefPubMedGoogle Scholar
  • 38 Lin YC, Tsai PH, Lin CY, Cheng CH, Lin TH, Lee KPH, Huang KY, Chen SH, Hwang JJ, Kandaswami CC, Lee MT. Impact of flavonoids on matrix metalloproteinase secretion and invadopodia formation in highly invasive A431-III cancer cells. PLoS One 2013; 8: e71903
    CrossrefPubMedGoogle Scholar
  • 39 Song NR, Chung MY, Kang NJ, Seo SG, Jang TS, Lee HJ, Lee KW. Quercetin suppresses invasion and migration of H-Ras-transformed MCF10A human epithelial cells by inhibiting phosphatidylinositol 3-kinase. Food Chem 2014; 142: 66-71
    CrossrefPubMedGoogle Scholar
  • 40 Friedl P, Wolf K. Tumour-cell invasion and migration: diversity and escape mechanisms. Nat Rev Cancer 2003; 3: 362-374
    CrossrefPubMedGoogle Scholar
  • 41 Ertel A, Verghese A, Byers SW, Ochs M, Tozeren A. Pathway-specific differences between tumor cell lines and normal and tumor tissue cells. Mol Cancer 2006; 5: 55
    CrossrefPubMedGoogle Scholar
  • 42 Guichard A, Humbert P, Tissot M, Muret P, Courderot-Masuyer C, Viennet C. Effects of topical corticosteroids on cell proliferation, cell cycle progression and apoptosis: in vitro comparison on HaCaT. Int J Pharm 2015; 479: 422-429
    CrossrefPubMedGoogle Scholar
  • 43 Kastelan M, Prpić-Massari L, Brajac I. Apoptosis in psoriasis. Acta Dermatovenerol Croat 2009; 17: 182-186
    PubMedGoogle Scholar
  • 44 Boukamp P, Petrussevska RT, Breitkreutz D, Hornung J, Markham A, Fusenig NE. Normal keratinization in a spontaneously immortalized aneuploid human keratinocyte cell line. J Cell Biol 1988; 106: 761-771
    CrossrefPubMedGoogle Scholar
  • 45 Maira SM, Stauffer F, Brueggen J, Furet P, Schnell C, Fritsch C, Brachmann S, Chene P, De Pover A, Schoemaker K, Fabbro D, Gabriel D, Simonen M, Murphy L, Finan P, Sellers W, Garcia-Echeverria C. Identification and characterization of NVP-BEZ235, a new orally available dual phosphatidylinositol 3-kinase/mammalian target of rapamycin inhibitor with potent in vivo antitumor activity. Mol Cancer Ther 2008; 7: 1851-1863
    CrossrefPubMedGoogle Scholar
  • 46 Liao J, Ku NO, Omary MB. Stress, apoptosis, and mitosis induce phosphorylation of human keratin 8 at Ser-73 in tissues and cultured cells. J Biol Chem 1997; 272: 17565-17573
    CrossrefPubMedGoogle Scholar
  • 47 Park K, Lee JH, Cho HC, Cho SY, Cho JW. Down-regulation of IL-6, IL-8, TNF-α and IL-1β by glucosamine in HaCaT cells, but not in the presence of TNF-α . Oncol Lett 2010; 1: 289-292
    PubMedGoogle Scholar